Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 200 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Subcutaneous atezolizumab for treating locally advanced or metastatic non-small-cell lung cancer	Atezolizumab (Tecentriq; MPDL3280A)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2022	View \| Download
Talquetamab for previously treated relapsed or refractory multiple myeloma	Talquetamab	Multiple myeloma (MM)	Haematological Cancer and Lymphomas	2022	View \| Download
Teclistamab for previously treated relapsed or refractory multiple myeloma	Teclistamab	Multiple myeloma (MM)	Haematological Cancer and Lymphomas	2022	View \| Download
Teclistamab with daratumumab for previously treated relapsed or refractory multiple myeloma	Daratumumab (Darzalex; JNJ-54767414) , Teclistamab	Multiple myeloma (MM)	Haematological Cancer and Lymphomas	2022	View \| Download
Teduglutide for short bowel syndrome in infants	Teduglutide	Short bowel syndrome	Gastroenterology	2022	View \| Download
Teplizumab for the delay of clinical type-1 diabetes in at-risk patients aged 8 years and over	Teplizumab (PRV-031; MGA031)	Type 1 diabetes	Endocrine Nutritional and Metabolic Disorders	2022	View \| Download
Tiragolumab with atezolizumab for previously untreated non-small cell lung cancer	Atezolizumab (Tecentriq; MPDL3280A) , Tiragolumab (RG-6058; MTIG7192A)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2022	View \| Download
Tiratricol for treating monocarboxylate transporter 8 deficiency (Allan-Herndon-Dudley syndrome)	Tiratricol	Monocarboxylate transporter 8 deficiency (Allan-Herndon-Dudley syndrome)	Genetic Disorders , Neurology	2022	View \| Download
Tirzepatide for treating obese or overweight adults	Tirzepatide (LY3298176)	Obesity	Cardiovascular System , Ear Nose and Throat (ENT)	2022	View \| Download
Tislelizumab for treating unresectable, previously untreated hepatocellular carcinoma	Tislelizumab (BGB-A317; BGBA-317)	Hepatocellular carcinoma (HCC)	Gastrointestinal Cancer	2022	View \| Download